Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
โ
of holders' portfolios
13F filers
1
institution
52-week range
$0.00 โ $0.56
0% from low
Exchange
OTC Link
CS
CARISMA THERAPEUTICS INC
No one on the platform currently holds CARM.
| Institution | Shares | Reported |
|---|---|---|
| Renaissance Technologiesas of 2025-09-30 | 293,686 | $80.5K |
| Execution date | Ratio |
|---|---|
| 2023-03-08 | 2-for-1 |
No one on the platform has traded CARM yet.
No recent Form 4 filings on EDGAR โ either no insider transactions reported recently or this isn't a SEC-registered issuer.
$CARM veteran of EBIO/SESN/CARM. Lost alot on 8.13.21. A hot mess. Still waiting for the big Roche payoff, ha ha.
View on StockTwits โ$CARM This stock would be a trader's dream ..... if brokers allowed it to trade.
View on StockTwits โ$CARM this looks like a great way to lose some money and never see it again!!! ๐๐คฃ๐ Iโm loading the up and watching it sink to the bottom ๐คช
View on StockTwits โ$SLS any diehard veteran investors of SESN/$CARM on the Sellas train? Just curious to see how life is after that awful Friday the 13th of 2021. I am fully recovered.
View on StockTwits โFundamental analysis of $CARM (Carisma Therapeutics Inc.) based on financial data and reported results. #CARM #Carisma
View on StockTwits โRecent $TICKER stream from stocktwits.com โ refreshed every 5 minutes. Sentiment tags are self-reported by posters. Not investment advice.
| Year | Est. revenue | Growth | Est. EPS | EPS range | Fwd P/E | # Analysts |
|---|---|---|---|---|---|---|
| 2026 | $9M | -39.2% | $-0.52 | $-0.52โ$-0.52 | โ | 1 |
| 2027 | $43M | +374.2% | $-0.44 | $-0.44โ$-0.44 | โ | 1 |
| 2028 | $10M | -76.9% | $-0.42 | $-0.42โ$-0.42 | โ | 1 |
| 2029 | $73M | +632.5% | $-0.42 | $-0.42โ$-0.42 | โ | 1 |
Forward consensus ยท growth is YoY vs the prior fiscal-year estimate ยท Fwd P/E at the current price ยท source: Financial Modeling Prep
Beat consensus in 4 of the last 7 reported quarters
| Reported | Est. EPS | Actual | Surprise |
|---|---|---|---|
| 2025-08-07 | $-0.12 | $-0.12 | +0.0% |
| 2025-05-13 | $-0.12 | $-0.22 | -83.3% |
| 2025-03-31 | $-0.16 | $-0.42 | -162.5% |
| 2024-11-07 | $-0.31 | $-0.31 | +0.0% |
| 2024-08-08 | $-0.36 | $-0.27 | +25.0% |
| 2024-05-09 | $-0.37 | $-0.46 | -24.3% |
| 2024-03-26 | $-0.55 | $-0.52 | +5.5% |
| $1M |
| โ |
| IMMXImmix Biopharma, Inc. | $10.92 | -3.96% | $594M | โ |
| IMNNImunon, Inc. | $1.58 | -1.86% | $7M | โ |
Source: Financial Modeling Prep ยท peers by sector/industry